Practice
Featured experience
Goldman Sachs $9.5 billion sale of Boyd Thermal and related business separations
We are advising Goldman Sachs Merchant Banking Division and its portfolio company Boyd on the transactions
REV Group $9 billion merger with Terex
We are advising REV Group on the transaction
Rent the Runway growth recapitalization
We advised Rent the Runway on the transactions
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
MDLIVE $50 million private placement
Davis Polk advised MDLIVE Inc. in connection with its private placement of approximately $50 million in shares of its Series…
Ranpak Holdings exchange offer and consent solicitation
Davis Polk advised Ranpak Holdings Corp. in connection with an offer to exchange shares of Class A common stock of the…
Emerson $1.6 billion acquisition of Open Systems International
Davis Polk is advising Emerson Electric Co. on its $1.6 billion acquisition of Open Systems International, Inc.
Emerson,…
Bristol Myers Squibb acquisition of Forbius
Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and…
Chaparral Energy chapter 11 restructuring and settlement of litigation
Davis Polk is advising Chaparral Energy, Inc. and its subsidiaries in connection with its restructuring under chapter 11 of…
Dufry $311 million going-private acquisition of Hudson
Davis Polk is advising Dufry AG in connection with its proposed acquisition of all the equity interests in Hudson Ltd. it…
CureVac $245.3 million IPO
Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which…
Roper Technologies $5.35 billion acquisition of Vertafore
Davis Polk is advising Roper Technologies, Inc. in connection with its $5.35 billion acquisition of Vertafore, a portfolio…
Freeline Therapeutics Holdings $158.8 million IPO
Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American…
Acutus Medical $170 million IPO
Davis Polk advised Acutus Medical, Inc. on its SEC-registered initial public offering of 10,147,058 shares of common stock…